BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm.
To learn more about BioStable Science and Engineering, visit www.biostable-s-e.com.
Tom Williamson is a top producing commercial executive with both large company and start up experience. Under Tom’s leadership, the Stryker Interventional Spine sales team became a revenue growth leader and established a strong foothold in the competitive vertebral compression fracture market. He then joined Entellus Medical where his last role was VP, Commercial Operations. He helped Entellus grow to over $100M in sales and was integral in their acquisition of Spirox and the final exit of Entellus to Stryker for $682M. Tom holds a Bachelor of Science degree in Chemical Engineering from Louisiana State University and has completed extensive leadership training at Harvard University.
Mr. Griffin earned a B.S. in civil engineering from Auburn University and an M.S. in material engineering from the University of Alabama-Birmingham. He was recently inducted as a Fellow in the American Institute for Medical and Biological Engineering and in 2006 was named to the Alabama Engineering Hall of Fame. Griffin holds two U.S. patents and has published and presented regularly to the engineering profession.